Clinical trial

Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in…

NCT00096278 · National Cancer Institute (NCI), NIH · Completed

Key facts

NCT number NCT00096278
Title Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
Official title A Phase III Clinical Trial Comparing Infusional 5-Fluorouracil (5-FU), Leucovorin, and Oxaliplatin (mFOLFOX6) Every Two Weeks With Bevacizumab to the Same Regimen Without Bevacizumab for the Treatment of Patients With Resected Stages II and III Carcinoma of the Colon
Lead sponsor National Cancer Institute (NCI), NIH
Collaborators NSABP Foundation Inc
Status Completed
Phase Phase 3
Study type Interventional
Conditions Colon Adenocarcinoma, Stage IIA Colon Cancer AJCC v7, Stage IIB Colon Cancer AJCC v7, Stage IIC Colon Cancer AJCC v7, Stage IIIA Colon Cancer AJCC v7, Stage IIIB Colon Cancer AJCC v7, Stage IIIC Colon Cancer AJCC v7
Intervention type Biological, Drug
Interventions Bevacizumab, Fluorouracil, Leucovorin Calcium, Oxaliplatin
Enrollment 2,710
Start date Sep 15, 2004
Primary completion Mar 12, 2009
Completion Dec 31, 2012
First posted Nov 9, 2004
Last update posted Jul 30, 2019
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies